DEA Diversion Enforcement News - February 2023

U.S. Drug Enforcement Administration sent this bulletin at 02/02/2023 11:00 AM EST

Having trouble viewing this email? View it as a Web page.

DEA Diversion Enforcement News

DEA’s Diversion Control Division strives to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources. When the safety and health of the American people is in jeopardy, DEA takes action against those who violate the law.

Read the latest enforcement cases and civil actions:

January 24, 2023

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

January 20, 2023

Chester County Doctor Pleads Guilty to Operating Pill Mill Out of Main Line Pain Clinic

January 11, 2023

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics

January 11, 2023

Former Doctor Convicted of Illegal Distribution of Controlled Substances

January 6, 2023

Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations

Read More

Follow DEA on social media @DEAHQ

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice Web site. Update your subscription to this service, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. If you have questions about the Department of Justice Web site, please contact webmaster@usdoj.gov.

GovDelivery is providing this service on behalf of the Department of Justice and may not use your subscription information for any other purposes.

Department of Justice Privacy Policy
GovDelivery Privacy Policy